Effect of lixisenatide on natriuretic peptides in people with type 2 diabetes and recent acute coronary syndrome: The ELIXA trial.

Ulagamadesan VenkatesanEmil WolskBrian ClaggettRafael DiazKenneth DicksteinSibylle HessLars KøberAldo P MaggioniJohn J V McMurrayJeffrey L ProbstfieldMatthew C RiddleJean-Claude TardifMarc A Pfeffer

Published in: Diabetes, obesity & metabolism (2023)

Keyphrases

acute coronary syndrome
phase iii
study protocol
percutaneous coronary intervention
antiplatelet therapy
phase ii
clinical trial
ejection fraction
amino acid
randomized controlled trial
open label
atrial fibrillation